Literature DB >> 8010295

Outcome of carpal tunnel surgery in Washington State workers' compensation.

M L Adams1, G M Franklin, S Barnhart.   

Abstract

All cases of occupational carpal tunnel syndrome (OCTS) who received surgery for this condition in the Washington State workers' compensation system were identified using claim and physician billing databases. One hundred ninety-one incident surgical cases were identified between July 1, 1987 and December 31, 1987, and were followed up a mean of 3 years postoperatively for clinical, disability, and return to work outcomes. Medical record and claim file review was required for clinical and employment information. The mean age of all patients was 36.6 years, 48% were female, and 40% received bilateral surgery. The mean time from claim filing to surgery was 187 days. Ninety-eight percent of cases met the National Institute for Occupational Safety and Health (NIOSH) case definition for OCTS. Relief of pain was complete or modest in 86% (124/145) and only 14% of cases reported no improvement in symptoms. Mean duration of disability (time loss) postoperatively was nearly 4 months, and 8% of cases exceeded 1 year of time loss. The majority of cases returned to their same job (67%) or to a different job (15%). Workers in high risk occupations were less likely to return to the same job after CTS surgery compared to those in lower risk occupations (61% vs. 75%, p = 0.08). In this population, no association was seen between any outcome and age, gender, marital status, or baseline wage. Duration of disability was not significantly related to preoperative severity of OCTS or to more specific case criteria for this condition.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8010295     DOI: 10.1002/ajim.4700250407

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  13 in total

Review 1.  Readiness for return to work following injury or illness: conceptualizing the interpersonal impact of health care, workplace, and insurance factors.

Authors:  Renée-Louise Franche; Niklas Krause
Journal:  J Occup Rehabil       Date:  2002-12

2.  Elongated muscle belly of the flexor digitorum superficial causing carpal tunnel syndrome.

Authors:  Antonios Kerasnoudis
Journal:  Hand (N Y)       Date:  2012-09

Review 3.  Policy-relevant research: when does it matter?

Authors:  Gary M Franklin; Thomas M Wickizer; Deborah Fulton-Kehoe; Judith A Turner
Journal:  NeuroRx       Date:  2004-07

4.  A cost analysis of staged and simultaneous bilateral carpal tunnel release.

Authors:  John C Elfar; Mohab B Foad; Susan L Foad; Peter J Stern
Journal:  Hand (N Y)       Date:  2012-09

Review 5.  Measuring return to work.

Authors:  Radoslaw Wasiak; Amanda E Young; Richard T Roessler; Kathryn M McPherson; Mireille N M van Poppel; Johannes R Anema
Journal:  J Occup Rehabil       Date:  2007-10-11

6.  Selection of operative procedures for cubital tunnel syndrome.

Authors:  Christine B Novak; Susan E Mackinnon
Journal:  Hand (N Y)       Date:  2008-09-19

Review 7.  Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies.

Authors:  D Rempel; B Evanoff; P C Amadio; M de Krom; G Franklin; A Franzblau; R Gray; F Gerr; M Hagberg; T Hales; J N Katz; G Pransky
Journal:  Am J Public Health       Date:  1998-10       Impact factor: 9.308

8.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

9.  Sickness absence after carpal tunnel release: a systematic review of the literature.

Authors:  Lisa Newington; Martin Stevens; David Warwick; Jo Adams; Karen Walker-Bone
Journal:  Scand J Work Environ Health       Date:  2018-08-12       Impact factor: 5.024

10.  Pre-surgery disability compensation predicts long-term disability among workers with carpal tunnel syndrome.

Authors:  June T Spector; Judith A Turner; Deborah Fulton-Kehoe; Gary Franklin
Journal:  Am J Ind Med       Date:  2012-03-05       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.